Eterna Therapeutics
ERNA
#10134
Rank
โ‚ฌ8.4 M
Marketcap
0,16ย โ‚ฌ
Share price
-22.93%
Change (1 day)
-92.44%
Change (1 year)

P/S ratio for Eterna Therapeutics (ERNA)

P/S ratio as of March 2025 (TTM): 15.2

According to Eterna Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.36. At the end of 2024 the company had a P/S ratio of 10.4.

P/S ratio history for Eterna Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202410.4-92.71%
2023143
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.35-91.16%๐Ÿ‡บ๐Ÿ‡ธ USA
13.6-10.42%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
2.85-81.30%๐Ÿ‡ซ๐Ÿ‡ท France
7.76-49.05%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2168-98.58%๐Ÿ‡ฆ๐Ÿ‡บ Australia
1.08-92.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel